Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial.

Psychological medicine(2022)

引用 5|浏览79
暂无评分
摘要
These exploratory results warrant further scrutiny, but demonstrate that quick and non-invasive behavioral tests may have substantial clinical value in predicting antidepressant treatment response.
更多
查看译文
关键词
Biomarkers,bupropion,cognitive control,depression,placebo response,reward learning,sertraline,treatment response
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要